Less Invasive Surfactant Administration versus Intubation, Surfactant Administration, and Extubation in Preterm Infants with Respiratory Distress Syndrome: A Randomized Controlled Trial
DOI:
https://doi.org/10.37018/KOIZ5593Keywords:
Respiratory Distress Syndrome, Preterm infants, Pulmonary Surfactants, Mechanical ventilationAbstract
Background: Respiratory distress syndrome (RDS) is one of the major causes of morbidity and mortality among preterm infants in Pakistan. Less Invasive Surfactant Administration (LISA) is a new and effective lung-protective technique; however, very few centers in Pakistan are using this, which may decrease the need for mechanical ventilation compared with the conventional INSURE (Intubation–Surfactant–Extubation) method. The objective of this study was to compare the need of mechanical ventilation requirement between LISA and INSURE techniques in spontaneously breathing preterm infants with RDS.
Methodology: This randomized controlled trial was conducted at the Neonatal Unit, Paediatric Department, Sir Ganga Ram Hospital, Lahore, from May to November 2023. The trial was registered at ClinicalTrials.gov under registration number NCT07910539. A total of 90 preterm infants (<35 weeks gestation) who were diagnosed with RDS were enrolled and randomly assigned to receive surfactant using either the LISA or INSURE technique. All infants with respiratory distress were initially stabilized on nasal CPAP. The primary outcome was to assess the need for mechanical ventilation within three hours of surfactant administration. Data were analyzed using SPSS 25, with p ≤0.05 considered statistically significant.
Results: Baseline demographic characteristics were similar in both groups. Mechanical ventilation was significantly lower in the LISA group (11/45; 24.4%) compared with the INSURE group (24/45; 53.3%) (p = 0.005). Subgroup analyses showed consistent benefits of the LISA technique across gender, gestational age, and birth-weight categories.
Conclusion: LISA significantly reduces the need for mechanical ventilation in preterm infants with RDS compared with INSURE.
References
1. Nawaz R, Khalid N, Ajmal F, Akbary MF, Gong S, Zhou Z, et al. The nexus between healthcare provider distribution and neonatal mortality based on the context of maternal and child healthcare services in Pakistan. J Health Popul Nutr. 2025;44:219.
doi:10.1186/s41043-025-00971-7.
2. Eshetu DM, Yewodiaw TK, Wubaye AM, Shitu BF, Delie AM, Haimanot AB, et al. Incidence and predictors of mortality among neonates with respiratory distress syndrome admitted to neonatal intensive care units in Ethiopia: a systematic review and meta-analysis of evidence from two regional states. BMC Pediatr. 2026;26:502. doi:10.1186/s12887-026-06877-5.
3. Rafiq A, Khan MA, Khan J. Respiratory distress syndrome among neonates: a cross-sectional survey. Pak J Phys Ther Rehabil. 2025;1(1).
4. Himayat M, Arif M, Iftikhar H, Khan K, Khan A, Faheem M. Frequency and factors of respiratory distress among neonates admitted to intensive care unit. J Health Wellness Community Res. 2025.
5. Tikmani SS, Saleem S, Sadia A, Bann CM, Bozdar MH, Raza J, et al. Predictors of preterm neonatal mortality in India and Pakistan: a secondary analysis of data from the PURPOSe study. Glob Pediatr Health. 2024;11:2333794X241236617.
6. Loft L, Tingay DG. Respiratory management of neonatal acute respiratory distress syndrome. JAMA Netw Open. 2026;9(3).
7. Hooda S, Dalal JS, Bhalla K, Vaswani ND, Dalal M. Less invasive surfactant administration (LISA) versus intubation surfactant extubation (InSurE) technique using higher volume surfactant in management of neonates with respiratory distress syndrome: an open-label randomized controlled trial. Eur J Pediatr. 2025;184(6):371. doi:10.1007/s00431-025-06191-9.
8. Kuitunen I, Halmesmäki E, Lehtonen L. Less invasive surfactant administration compared to intubation-surfactant-rapid extubation method in preterm neonates: an umbrella review. Neonatology. 2024;121(4):485-498.
9. Härtel C, Kribs A, Göpel W, Dargaville P, Herting E. Less invasive surfactant administration for preterm infants: state of the art. Neonatology. 2024;121(5):584-595.
10. Cho H, Lee J. Neonatal outcomes of the intubation-surfactant-extubation versus less invasive surfactant administration method: a national cohort study in Korea. Neonatology. 2025;122:714-721.
11. Luna MS, Unnebrink K, Martinez-Tristani M, Navarro CR. Less invasive surfactant administration: a review of current evidence of clinical outcomes with beractant. Cureus. 2022;14(10).
12. Veintemilla-Burgos F, Minchalo-Ochoa G, Balda S, Diaz-Djevoich I, Kronfle R, Panchana-Lascano M, et al. Tiny lungs, big decisions: a meta-analysis comparing minimally invasive surfactant therapy versus intubation-surfactant-extubation in preterm neonates with respiratory distress syndrome. Int J Pediatr. 2025;2025:8045343.
13. Dargaville PA, Kamlin CO, Orsini F, Wang X, De Paoli AG, Kutman HG, et al. Two-year outcomes after minimally invasive surfactant therapy in preterm infants: follow-up of the OPTIMIST-A randomized clinical trial. JAMA. 2023;330(11):1054-1063.
14. Anand R, Nangia S, Kumar G, Mohan MV, Dudeja A. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized controlled trial. Sci Rep. 2022;12(1):21955.
15. Xu CC, Bao YY, Zhao JX, Cheng K, Sun L, Wu JY, et al. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center retrospective study from China. BMC Pulm Med. 2022;22:462.
16. Thodika FM, Ambulkar H, Williams E, Bhat R, Dassios T, Greenough A. Outcomes following less-invasive surfactant administration in the delivery room. Early Hum Dev. 2022;167:105562.
17. Katheria A, Ines F, Banerji A, Hopper A, Uy C, Chundu A, et al. Caffeine and less invasive surfactant administration for respiratory distress syndrome of the newborn. NEJM Evid. 2023;2(12).
18. Mukhtar-Yola M, Farouk ZL, Ashiru Usman H, Okolo AA, Ajanwenyi J, Omoyibo E, et al. Implementing less invasive surfactant administration in Nigeria: a prospective cohort study with a retrospective matched control. Lancet Reg Health Afr. 2026: 100044. doi:10.1016/j.lanafr.2026.100044.
19. Mishra A, Joshi A, Londhe A, Deshmukh L. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial. Pediatr Pulmonol. 2023;58(3):738-745.
20. Mengstie LA, Zeneb W, Tessema M, Abemie W, Beshahured AA, Dessie YA, et al. Incidence and predictors of mortality among low birth weight neonates in Africa: a systematic review and meta-analysis. Front Pediatr. 2025;13:1458871.
21. Mansouri M, Servatyari K, Rahmani K, Sheikhahmadi S, Hemmatpour S, Eskandarifar A, et al. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis. J Neonatal Perinatal Med. 2024;17(2):233-239. doi:10.3233/NPM-230194.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Bilal Waheed, Asma Anwar, Muhammad Asif Siddiqui, Aneela Anjum, Zainab Aziz, Naveed Akbar Hutiyana

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.